Global  

Trusted News Discovery Since 2008
One News Page
One News Page > Business News > Co-Diagnostics expects to roll out its coronavirus detection test in Europe shortly

Co-Diagnostics expects to roll out its coronavirus detection test in Europe shortly

Proactive Investors Thursday, 20 February 2020
Co-Diagnostics (NASDAQ:CODX) is on the receiving end of good news as its Logix Smart COVID-19 test, which detects the deadly coronavirus, is close to being rolled out across the European Union after being submitted for formal EU registration. This novel test uses the Utah diagnostics company’s CoPrimer technology to identify the presence of a ribonucleic acid (RNA) associated with a new strain of the sometimes fatal virus, which first struck in the city of Wuhan in China late last year. The virus has since spread from China to infect more than 75,000 people and cause nearly 2,130 deaths, according to data cited by Johns Hopkins Center for Systems Science and Engineering. READ: Co-Diagnostics receives new orders for its vector control tests, equipment from mosquito abatement districts The coronavirus diagnostic test is expected to be available this month in European countries which accept the highly sought-after CE marking as valid regulatory approval. “We are pleased to announce this milestone, which comes after weeks of hard work by our team at Co-Diagnostics to develop a high-performance diagnostic to help prevent the spread of the new strain of coronavirus,” says Dwight Egan, CEO of Co-Diagnostics. “Our patented CoPrimer molecules have unique properties that lead to a significant reduction in false positive test results over other polymerase chain reaction (PCR), but will also allow for enhanced multiplexing, or identifying multiple targets at once, as we iterate the test to include other strains of coronavirus and mutations of COVID-19.” The dossier with the relevant technical file, which was submitted to the Utah company’s European representative, includes a description of the test to support its compliance with the necessary standards to win a CE mark. This information will confirm the test meets the requirements of the European Union’s In-Vitro Diagnostic (IVD) Medical Device directive. Co-Diagnostics will manufacture its coronavirus diagnostic test in a plant set up for the manufacturing of IVD medical devices in Utah. Earlier this month, Co-Diagnostics’ coronavirus diagnostic test caught the eye of analysts at Maxim Group. Enthusiastic about its introduction in China, Maxim analysts tagged the company with a Buy rating and increased its price target to $5 from $2, citing the speed at which the company developed the detection test and its first sales in China. Co-Diagnostics shares moved 6.3% higher to hit $3.20 in afternoon trade on Thursday.
0
shares
ShareTweetSavePostSend
 

You Might Like


Recent related videos from verified sources

Don't fall for these coronavirus scams [Video]

Don't fall for these coronavirus scams

Although we are seeing the best of humanity during the coronavirus pandemic, people helping people, reaching out, watching out for each other, there are some people who are trying to take advantage of..

Credit: TODAY’S TMJ4     Duration: 01:48Published
Baker Wants To Be Incredibly Careful About Preventing 'Insidious' Coronavirus From Coming Back [Video]

Baker Wants To Be Incredibly Careful About Preventing 'Insidious' Coronavirus From Coming Back

“I will be incredibly careful about not permitting this insidious, awful, and horribly dangerous and contagious virus from coming back anytime soon,” Mass. Gov. Charlie Baker told reporters..

Credit: WBZ CBS Boston     Duration: 02:19Published

Recent related news from verified sources

FDA authorizes first coronavirus blood test

The FDA has authorized the first blood test for the coronavirus, which could identify people who have been exposed to the virus but do not show any symptoms. Dr....
CBS News Also reported by •bizjournalsAnorak

Stock Alert: Co-Diagnostics Gains After Its Covid-19 Test Gets EUA

Shares of Co-Diagnostics, Inc. (CODX) are climbing more than 20% Monday morning after the molecular diagnostics company announced that its Logix Smart...
RTTNews Also reported by •Proactive Investors

Tweets about this



Environmentally friendly: One News Page is hosted on servers powered solely by renewable energy
© 2020 One News Page Ltd. All Rights Reserved.
About us  |  Contact us  |  Disclaimer  |  Press Room  |  Terms & Conditions  |  Content Accreditation
 RSS  |  News for my Website  |  Free news search widget  |  In the News  |  DMCA / Content Removal  |  Privacy & Data Protection Policy
How are we doing? FeedbackSend us your feedback  |   LIKE us on Facebook   FOLLOW us on Twitter  •  FOLLOW us on Pinterest
One News® is a registered trademark of One News Page Ltd.